Paradigm Capital Management Inc’s Eton Pharmaceutcials ETON Stock Holding History

Paradigm Capital Management Inc’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-200,000	Closed	-$2.66M	–	130
2024 Q4	$2.66M	Sell	200,000 -100,000	-33%	-$1.01M	0.12%	72
2024 Q3	$1.8M	Hold	300,000	–	–	0.08%	86
2024 Q2	$987K	Hold	300,000	–	–	0.05%	97
2024 Q1	$1.13M	Hold	300,000	–	–	0.05%	97
2023 Q4	$1.31M	Hold	300,000	–	–	0.07%	88
2023 Q3	$1.25M	Hold	300,000	–	–	0.07%	86
2023 Q2	$1.05M	Hold	300,000	–	–	0.06%	96
2023 Q1	$1.16M	Hold	300,000	–	–	0.08%	89
2022 Q4	$840K	Hold	300,000	–	–	0.06%	108
2022 Q3	$630K	Buy	300,000 +100,000	+50%	+$249K	0.05%	116
2022 Q2	$524K	Buy	200,000 +100,000	+100%	+$336K	0.04%	121
2022 Q1	$436K	Buy	100,000 +10,000	+11%	+$39.3K	0.02%	133
2021 Q4	$386K	Buy	+90,000	New	+$430K	0.02%	146

Other funds holding ETON

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

NPT

National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Paradigm Capital Management Inc's ETON Position: Q1 2025 in Review

Paradigm Capital Management Inc sold out of Eton Pharmaceutcials (ETON) in Q1 2025, closing a stake of 200,000 shares — an estimated $2.66M sold.

Paradigm Capital Management Inc first reported a position in ETON in Q4 2021 and held it in 13 quarters. The position peaked at $2.66M in Q4 2024. 86 funds tracked by Wall St. Rank hold ETON as of Q1 2025.

Paradigm Capital Management Inc reported no remaining Eton Pharmaceutcials position as of Q1 2025 after selling out during the quarter.
Paradigm Capital Management Inc sold 200,000 Eton Pharmaceutcials shares in Q1 2025, an estimated $2.66M.
Paradigm Capital Management Inc first reported a position in Eton Pharmaceutcials in Q4 2021 and held it in 13 quarters.
Paradigm Capital Management Inc's Eton Pharmaceutcials position peaked at $2.66M in Q4 2024.
86 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2025.

Based on Paradigm Capital Management Inc's 13F filing for Q1 2025, filed 15 May 2025.